25 Stocks Moving In Wednesday's Pre-Market Session


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Gainers

  • China Ceramics Co., Ltd. (NASDAQ:CCCL) rose 28.1 percent to $2.60 in pre-market trading after climbing 40.97 percent on Tuesday.
  • First Data Corporation (NYSE:FDC) rose 26 percent to $22.09 in pre-market trading after Fiserv Inc (NASDAQ:FISV) announced plans to buy the company in an all-stock transaction for equity value of $22 billion.
  • Microbot Medical Inc (NASDAQ:MBOT) shares rose 14.7 percent to $10.41 in pre-market trading after falling 7.25 percent on Tuesday.
  • Ability Inc. (NASDAQ:ABIL) rose 14.6 percent to $2.36 in pre-market trading after surging 11.35 percent on Tuesday.
  • Innovate Biopharmaceuticals, Inc. (NASDAQ:INNT) shares rose 11.4 percent to $2.44 in pre-market trading.
  • Luna Innovations Incorporated (NASDAQ:LUNA) rose 6.1 percent to $3.53 in pre-market trading.
  • United Continental Holdings, Inc. (NASDAQ:UAL) rose 5.8 percent to $85.90 in pre-market trading after the company reported stronger-than-expected earnings for its fourth quarter on Tuesday.
  • Inpixon (NASDAQ:INPX) shares rose 5.6 percent to $2.46 in pre-market trading. Inpixon closed oversubscribed rights offering with gross proceeds of $12.0 million.
  • Altimmune, Inc. (NASDAQ:ALT) rose 5.5 percent to $2.89 in pre-market trading after gaining 3.01 percent on Tuesday.
  • Helius Medical Technologies, Inc. (NASDAQ:HSDT) rose 5.3 percent to $8.79 in pre-market trading.
  • The Bank of New York Mellon Corporation (NYSE:BK) rose 5 percent to $51.90 in pre-market trading following upbeat quarterly earnings.
  • Bank of America Corporation (NYSE:BAC) rose 4.8 percent to $27.83 in pre-market trading after the bank reported stronger-than-expected earnings for its fourth quarter.
  • Uxin Limited (NASDAQ:UXIN) rose 4 percent to $3.72 in pre-market trading after surging 8.48 percent on Tuesday.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Electronics For Imaging, Inc. (NASDAQ:EFII) fell 22.2 percent to $21.14 in pre-market trading after the company lowered its guidance for the quarter.
  • Neonode Inc. (NASDAQ:NEON) fell 13.2 percent to $2.44 in pre-market trading after rising 3.31 percent on Tuesday.
  • Kitov Pharma Ltd (NASDAQ:KTOV) fell 11.4 percent to $2.48 in pre-market trading after gaining 169.23 percent on Tuesday.
  • Adient plc (NYSE:ADNT) shares fell 11.4 percent to $16.22 in pre-market trading after reporting preliminary results for its first quarter.
  • PG&E Corporation (NYSE:PCG) fell 10.9 percent to $6.16 in pre-market trading after dropping 17.54 percent on Tuesday.
  • Snap Inc. (NYSE:SNAP) fell 9.8 percent to $5.90 in pre-market trading after CFO Tim Stone announced intention to resign.
  • Nordstrom, Inc. (NYSE:JWN) fell 9.1 percent to $43.00 in pre-market trading. Nordstrom reported a 1.3 percent year-over-year rise in its holiday comps. The company expects FY18 adjusted earnings of $3.55-$3.65 per share at low end of range.
  • Pearson plc (NYSE:PSO) fell 7.3 percent to $11.69 in pre-market trading after reporting a 5 percent drop in revenue at a key U.S. business.
  • Hexindai Inc. (NASDAQ:HX) fell 7.1 percent to $2.62 in pre-market trading after rising 6.02 percent on Tuesday.
  • Revance Therapeutics Inc (NASDAQ:RVNC) fell 5.6 percent to $19.06 in pre-market trading after reporting a $100-million common stock offering.
  • Stemline Therapeutics, Inc. (NASDAQ:STML) shares fell 4 percent to $9.55 in pre-market. Stemline Therapeutics priced its upsized 8.8 million share public offering of common stock at $9 per share.
  • Fiserv, Inc. (NASDAQ:FISV) fell 3.7 percent to $72.27 in pre-market trading after the company announced plans to buy First Data in an all-stock transaction for equity value of $22 billion.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneral#PreMarket GainersBiotechnologyHealth CareInformation TechnologyIT Consulting & Other ServicesLosersTop Gainers